Showing results (61-70 of 111) with videos related to
Sort By:
Pageof 12
The Journal of Physical Chemistry. B|September 21, 2016
Origin of Stereoselectivity and Substrate/Ligand Recognition in an FAD-Dependent R-Selective Amine OxidaseShogo Nakano, Kazuyuki Yasukawa, Takaki Tokiwa, et al.Internal Medicine (Tokyo, Japan)|July 24, 2024
Clinicopathological Features of Methotrexate-associated Lymphoproliferative Disorders in the Gastrointestinal TractTakeya Edagawa, Hiroyoshi Iwagami, Takuji Akamatsu, et al.Biomedical Reports|December 1, 2017
Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesionsKimihito Fujii, Rie Watanabe, Takahito Ando, et al.Biochemistry|May 23, 2018
Benchmark Analysis of Native and Artificial NAD<sup>+</sup>-Dependent Enzymes Generated by a Sequence-Based Design Method with or without Phylogenetic DataShogo Nakano, Tomoharu Motoyama, Yurina Miyashita, et al.DEN Open|February 6, 2023
Two cases of esophageal basaloid squamous cell carcinoma which achieved long-term survival by endoscopic submucosal dissection and additional chemoradiotherapyYoshiki Morihisa, Hiroyoshi Iwagami, Takuji Akamatsu, et al.International Journal of Molecular Sciences|January 16, 2020
Elucidation of Molecular Mechanism of a Selective PPARα Modulator, Pemafibrate, through Combinational Approaches of X-ray Crystallography, Thermodynamic Analysis, and First-Principle CalculationsMayu Kawasaki, Akira Kambe, Yuta Yamamoto, et al.ACS Medicinal Chemistry Letters|March 16, 2023
Ligand Screening System for the RXRα Heterodimer Using the Fluorescence RXR Agonist CU-6PMNMayu Kawasaki, Tomoharu Motoyama, Shoya Yamada, et al.Clinical Journal of Gastroenterology|June 9, 2026
A case of small undifferentiated pancreatic carcinoma detected during follow-up for focal pancreatic parenchymal atrophy with fatty replacementNobukazu Agatsuma, Kosuke Minaga, Ryuko Nakayama, et al.Bioscience, Biotechnology, and Biochemistry|April 12, 2021
Trp-Trp acts as a multifunctional blocker for human bitter taste receptors, hTAS2R14, hTAS2R16, hTAS2R43, and hTAS2R46Ichie Ojiro, Hiromi Nishio, Toyomi Yamazaki-Ito, et al.Breast Cancer (Tokyo, Japan)|November 18, 2019
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 EditionTakayoshi Uematsu, Kazutaka Nakashima, Mari Kikuchi, et al.Pageof 12